Assessment of the efficacy and tolerability of a topical formulation containing caffeine and Procapil 3% for improvement of male pattern hair loss

J Cosmet Dermatol. 2024 Apr;23(4):1492-1494. doi: 10.1111/jocd.16102. Epub 2023 Nov 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Topical
  • Alopecia* / drug therapy
  • Caffeine* / adverse effects
  • Humans
  • Male
  • Minoxidil
  • Treatment Outcome

Substances

  • Caffeine
  • Minoxidil